| Date | Title | Description |
| 17.04.2023 | L’obésité : la pandémie silencieuse du 21ème siècle | Infographie - obésité
La solution efficace pour les patients adultes pourrait être la multidisciplinarité et les nouvelles techniques endoscopiques non invasive.
Apollo Endosurgery, Inc. (NASDAQ:APEN)PARIS, FRANCE, April 17, 2023/EINPresswi... |
| 12.04.2023 | Globesity: the silent pandemic of the 21st century | Obesity in the UK infographic
Multidisciplinary and new incisionless endoscopic technique may be an effective solution for adult patients.
Apollo Endosurgery, Inc. (NASDAQ:APEN)LONDON, UNITED KINGDOM, April 12, 2023/EINPresswire.com/ -- Ahm... |
| 07.11.2022 | Apollo Endosurgery to Participate in Upcoming Investor Conferences | AUSTIN, TX / ACCESSWIRE / November 7, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced that its senior m... |
| 01.11.2022 | Apollo Endosurgery, Inc. Reports Record $19.6 million Global Revenue in Third Quarter 2022 | Grew global revenue 20% GAAP, 24% in constant currency
Received FDA authorization for Apollo ESGTM and Apollo REVISETM systems for treating patients with obesity
AUSTIN, TX / ACCESSWIRE / November 1, 2022 / Apollo Endosurgery, Inc. ("A... |
| 02.08.2022 | Apollo Endosurgery, Inc. Reports Record Global Revenue in Second Quarter 2022 | Grew global revenue 16% (20% in constant currency) as adoption increased across all product lines
Secured FDA marketing authorization for Apollo ESGTM and Apollo REVISETM
AUSTIN, TX / ACCESSWIRE / August 2, 2022 / Apollo Endosurgery, Inc. (... |
| 29.07.2022 | Apollo Endosurgery Announces Publication in the Lancet of Landmark Study for the Endoscopic Sleeve Gastroplasty Procedure | Publication of MERIT Study Follows FDA Market Authorization of Apollo ESG™
AUSTIN, TX / ACCESSWIRE / July 29, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gast... |
| 31.05.2022 | Digestive Disease Week 2022 Adds to the Growing Wave of Clinical Evidence Supporting Significant Opportunity for Apollo Endosurgery Products | AUSTIN, TX / ACCESSWIRE / May 31, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced highlights today from data ... |
| 18.05.2022 | Apollo Endosurgery Products to Take Center Stage at Digestive Disease Week | AUSTIN, TX / ACCESSWIRE / May 18, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that Apollo products ... |
| 04.04.2022 | Apollo Endosurgery Appoints Jeannette Bankes to Board of Directors | Veteran Brings 30 Years of Multinational Healthcare Leadership Experience
AUSTIN, TX / ACCESSWIRE / April 4, 2022 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastr... |
| 18.01.2022 | Apollo Endosurgery : Appoints Keely Scamperle as Vice President of Reimbursement and Market Access | Apollo Endosurgery Appoints Keely Scamperle as Vice President of Reimbursement and Market Access January 18, 2022
Veteran Leader Brings 25 Years of Global Medical Device Experience
AUSTIN, TX / ACCESSWIRE / January 18, 2022 / Apollo Endosur... |
| 11.01.2022 | Apollo Endosurgery : Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020 | Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020 January 10, 2022
Fourth quarter 2021 revenue grew 25% over 2020
AUSTIN, TX / ACCESSWIRE / January 10, 2022 / Apollo Endosurgery, Inc. ("Apol... |
| 11.01.2022 | Apollo Endosurgery : Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020 - Form 8-K | Apollo Endosurgery Announces Preliminary 2021 Revenue Results; Reflecting 50% Growth Over 2020
Fourth quarter 2021 revenue grew 25% over 2020
AUSTIN, Texas (January 10, 2022) - Apollo Endosurgery, Inc. ("Apollo" or the "Compa... |
| 22.12.2021 | Apollo Endosurgery : Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC | Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC December 21, 2021
$35 million funded at close to refinance existing debt, extend maturity and lower interest expense
Additi... |
| 22.12.2021 | Apollo Endosurgery : Announces New $100 Million Senior Secured Term Loan Facility from Innovatus Capital Partners, LLC - Form 8-K | Apollo Endosurgery Announces New $100 Million Senior Secured Term Loan Facility
from Innovatus Capital Partners, LLC
$35 million funded at close to refinance existing debt, extend maturity and lower interest expense
Additional borrowing cap... |
| 01.11.2021 | Apollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET | Apollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET November 01, 2021
AUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc.... |
| 23.10.2021 | Apollo Endosurgery : Announces Positive MERIT-Trial Outcomes | Apollo Endosurgery Announces Positive MERIT-Trial Outcomes October 22, 2021
Trial Results Demonstrate ESG Procedure Offers Significant and Durable Weight Loss, with Improvements in Obesity-Related Health Conditions
MERIT-Trial met its prima... |
| 15.10.2021 | Apollo Endosurgery : Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares | Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares October 15, 2021
AUSTIN, TX / ACCESSWIRE / October 15, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), ... |
| 13.10.2021 | Apollo Endosurgery : Announces Pricing of $65 Million Public Offering of Common Stock | Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock October 12, 2021
AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive ... |
| 12.10.2021 | Apollo Endosurgery : Announces Commencement of Public Offering of Common Stock | Apollo Endosurgery Announces Commencement of Public Offering of Common Stock October 12, 2021
AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical... |
| 07.10.2021 | Apollo Endosurgery : Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates | Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates October 07, 2021
Revenue expected between $16.0 million and $16.4 million
Third consecutive quarter of double-digit revenue growth; ... |
| 03.08.2021 | Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET | Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET August 03, 2021
AUSTIN, TX / ACCESSWIRE / August 3, 2021 / Apollo ... |
| 27.07.2021 | Apollo Endosurgery : to Report Second Quarter Financial Results on August 3, 2021 | Apollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021 July 27, 2021
AUSTIN, TX / ACCESSWIRE / July 27, 2021 / Apollo Endosurgery, Inc. ('Apollo') (NASDAQ:APEN), a global leader in next-generation minimally invasive... |
| 03.05.2021 | APOLLO ENDOSURGERY, INC.
Apollo Endosurgery : Announces Appointments to Commercial Leadership Team | Apollo Endosurgery Announces Appointments to Commercial Leadership Team May 03, 2021
Kirk Ellis to Serve as Vice President of US Sales
Steve Bosrock to Serve as Vice President of Marketing & Medical Education
AUSTIN, TX / ACCESSWIRE / M... |
| 28.04.2021 | APOLLO ENDOSURGERY, INC.
Apollo Endosurgery : to Report First Quarter Financial Results on May 4, 2021 | Apollo Endosurgery to Report First Quarter Financial Results on May 4, 2021 April 28, 2021
AUSTIN, TX / ACCESSWIRE / April 28, 2021 / Apollo Endosurgery, Inc. ('Apollo') (NASDAQ:APEN), a global leader in next-generation minimally invasive m... |
| 21.04.2021 | APOLLO ENDOSURGERY, INC.
Apollo Endosurgery : Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking System | Apollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking System April 21, 2021
Authors conclude, 'Compared to TTS clip, X-Tack is superior for effecting large mucosal defect closure, including... |
| 14.06.2019 | Apollo Endosurgery updates labeling on intragastric balloon | Apollo Endosurgery (NSDQ:APEN) said today that the FDA has approved its proposed labeling updates for the Orbera intragastric liquid-filled balloon system, which is used to treat obesity.
The goal of the labeling updates is to improve patie... |
| 12.09.2016 | PTV Healthcare-backed Apollo Endosurgery and Lpath to Merge | Lpath, Inc. (Nasdaq: LPTN) and Apollo Endosurgery, Inc. today announced that they have entered into a definitive merger agreement under which the security holders of Apollo would become the majority owners of Lpath. Under terms of the agree... |
| 12.09.2016 | H.I.G. BioHealth-backed Apollo Endosurgery and Lpath to Merge | Lpath, Inc. (Nasdaq: LPTN) and Apollo Endosurgery, Inc. today announced that they have entered into a definitive merger agreement under which the security holders of Apollo would become the majority owners of Lpath. Under terms of the agree... |
| 30.08.2016 | Zillion raises $28M for digital patient engagement platform | Norwalk, Connecticut-based Zillion, which makes an cloud-based patient engagement platform, has raised $28 million in Series C fundraising in a round led by TwinFocus Capital Partners. The funding will be used expand Zillion’s customer base... |
| 11.03.2015 | Apollo Endosurgery secures $50m loan | Apollo Endosurgery said it secured a $50 million term loan from Athyrium Capital Management it plans to use to refinance its debt.
The maker of bariatric and gastrointestinal surgical products said it plans to use the cash to repay loans us... |
| 18.12.2013 | Apollo Endosurgery Receives $50 Million in Financing | Apollo Endosurgery has received $50 million round of debt financing from Oxford Finance LLC.
Other investors in the deal for the Austin-based company included MidCap Financial and East West Bancorp.
Proceeds of the term loan are being used ... |
| 06.02.2012 | Apollo Endosurgery Inc. Lands $47.6 million in Financing | Who’s got $47.6 million in new financing?
That would be Apollo Endosurgery Inc. The Austin-based medical device maker announced that it has landed a big round of funding to develop its line of minimally invasive, scarless surgical procedure... |
| 08.10.2007 | Life sciences briefing: Monday, Oct. 8, 2007 | Featured companies: AirInSpace, Anacor Pharmaceuticals, Apollo Endosurgery, Ascension Health Partners, BG Medicine, CeraPedics, GlaxoSmithKline, Simplex Diabetic Supply, Zars Pharma
UPDATED: Last entry added at 2am PT on 10/8/07.
Anacor Pha... |
